NHS allows external contractors access to identifiable patient data, says report

Officials state growing concern over sensitive data access

Internal briefing note reportedly warned that external contractors working on the NHS Federated Data Platform could gain broad access to identifiable patient records before pseudonymisation.

The NHS has granted staff from companies including Palantir 'unlimited access' to ‌identifiable patient data whilst working on the Federated Data Platform project, reports the Financial Times, citing an internal briefing note.

Reuters could not immediately verify the report and Palantir and NHS did not immediately respond to Reuters' requests for comment.

The report says that NHS England has agreed to create an "admin" role granting ⁠non-staff "unlimited access" to the National Data Integration Tenant (NDIT), which is described as a "safe haven for data" ‌before it is "pseudonymised" ⁠and shared with other systems.

This means that the patient data in the NDIT is identifiable.

NHS FDP contract – opacity remains

The NDIT is housed under the Federated Data Platform project, which will link disparate NHS datasets into a single system.

Palantir won a ‌330-million-pound ($448.4 million) contract to develop the platform in 2023 at the end of a bidding process which drew criticisms for being much shorter than usual and less transparent. The process was subjected to two separate legal challenges but still stands. NHS England republished the contract – with fewer redactions – after a challenge by The Good Law Project.

"This is not only about Palantir, hence we have referred to non-NHSE staff, but there is currently considerable public interest and ‌concern about how much access to patient data Palantir/Palantir staff have," the briefing note viewed by the FT said.

The note also recommends capping external admin access to the NDIT and making ‌such permissions time-limited and subject to regular review.

Palantir role attracts greater scrutiny

Palantir has secured since secured contracts with the MoD and Financial Conduct Authority since winning the FDP bid, but multiple reports have surfaced over the last few months of ministers and officials seeking advice on whether they can use a break clause in the contract.

Officials, MPs and campaigners are concerned not just about whether the enormous contract offers the best value for money, but also about the implications for UK data sovereignty and governance of tying the NHS to such a controversial, US company with well-known links to intelligence and defence sectors.

A decision on is expected sometime in February 2027.